T
Tango Therapeutics, Inc. (TNGX)
NGM – Real Time Price. Currency in USD
19.26
-0.60 (-3.02%)
At close: Mar 27, 2026, 4:00 PM EDT
19.38
+0.12 (0.62%)
After-hours: Mar 27, 2026, 6:55 PM EDT
Get all premium features to the best stock analysis tool
NGM – Real Time Price. Currency in USD
19.26
-0.60 (-3.02%)
At close: Mar 27, 2026, 4:00 PM EDT
19.38
+0.12 (0.62%)
After-hours: Mar 27, 2026, 6:55 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 16.32 | 6.05 | 10 | |
| Quick ratio | 16.32 | 5.63 | 10 | |
| Debt to Equity | 0.10 | 0.30 | 9.0 | |
| Debt to Assets | 0.08 | 1.04 | 9.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 25M | 37M | 42M | 62M | 62M |
| Gross Profit | 21M | 34M | 40M | 60M | 60M |
| Operating Income | -111M | -114M | -146M | -111M | -111M |
| Net Income | -108M | -102M | -130M | -102M | -102M |
| EBITDA | -107M | -112M | -143M | -109M | -109M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -86.9 | 13.21 | 4.5 |
| Next quarter | -39.99 | 7.91 | 3.5 |
| Current year | -88.13 | -48.18 | 1.0 |
| Next year | -39.41 | -14.63 | 1.0 |
| Weighted average score | 2.5 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -99.99 | -343.94 | -307.13 | 3.74 | 1.8 |
| Y/Y | -99.99 | -2.85 | 17.14 | 18.58 | 5.0 |
| 3y average | 36.8 | -0.02 | 9.64 | -6.25 | 4.5 |
| 5y average | 92.27 | -19.56 | -0.47 | -59.6 | 3.3 |
| Weighted average score | 3.7 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $112.7M significantly exceed its total debt $33.6M, ensuring strong financial flexibility
Total current assets $353.8M exceed Total current liabilities $21.7M, highlighting excellent liquidity
Debt-to-equity ratio (0.1) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$29.9M limits the company's ability to reinvest or pay down debt